Metabolism of R- and S-Warfarin by CYP2C19 into Four Hydroxywarfarins

E-ISSN： 1874-0758|6|3|157-164

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.6, Iss.3, 2012-09, pp. : 157-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of Three CYP3A Isoforms to Metabolism of R- and S-Warfarin

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 213-219

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxylation of R (+)- and S (−)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Genotypes

By Shiohira Hideo

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2310-2316

Springer Publishing Company

Access to resources Recommend Favorite

In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6

By Weiss Johanna

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Iss. 3, 2008-09 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

Limitations of S-Warfarin Truncated Area Under the Concentration-Time Curve to Predict Cytochrome P450 2c9 Activity

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-06 ,pp. : 94-101

Bentham Science Publishers

Access to resources Recommend Favorite

Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese

By Yasumori T. Narita H. Matsuda T. Takubo T. Ogawa M. Ishii M. Hara K. Ishii Y. Okuyama K. Fujimoto G. Ochiai H. Kano A. Hasegawa S. Sato K. Taniguchi T.

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 939-946

Springer Publishing Company

Access to resources Recommend Favorite